LAURA INGRAHAM (HOST): Do you apply the same analysis to early intervention drugs such as ivermectin?
HARVEY RISCH (EPIDEMIOLOGIST): Well the same motivation for government agencies like the FDA and NIH committees to block uses of those medications -- hydroxychloroquine and ivermectin are demeaned and discarded by those committees because they are a threat to higher-priced medications and vaccines.